Navigation Links
Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports
Date:5/25/2013

New York, New York (PRWEB) May 25, 2013

Pradaxa lawsuits filed on behalf of patients who allegedly suffered serious, life-threatening episodes of internal bleeding while using the blood thinner continue to mount in a federal litigation underway in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. According to a posting on the Court’s website, 818 Pradaxa side effect claims had been filed in the litigation as of May 24, 2013. That’s up from 705 claims reported by the Court on May 15th. ( In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“We are not surprised that the Pradaxa lawsuits filed in this litigation are increasing at such a rapid rate. Our Firm receives inquiries on a regular basis from Pradaxa patients who have allegedly suffered serious instances of internal bleeding,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free Pradaxa side effect lawsuit evaluations to anyone who suffered internal bleeding while using the blood thinner.

Pradaxa Side Effects
Plaintiffs with claims pending in the Pradaxa side effect litigation allege that Boehringer Ingelheim failed to adequately warn that there is no readily-available antidote for internal bleeding that is sometimes associated with use of the blood thinner. According to a Bloomberg.com report published in December 2012, regulators in several countries have issued alerts regarding Pradaxa’s potential to cause dangerous internal bleeding in some patients.* Pradaxa was supposed to be an improvement over warfarin, a decades old blood thinner. However, warfarin bleeding can be stopped via the administration of vitamin K, while dialysis is the only available treatment for this Pradaxa side effect.    However, research published In May 2012 in the Journal of Neurosurgery indicated that dialysis is risky and may not be administered in enough time to stop Pradaxa bleeding.**

Since the publication of that study, additional research has indicated that Pradaxa bleeding is far more dangerous than the hemorrhaging that sometimes occurs with warfarin. In January, for example, a study of FDA hemorrhage cases published in the Institute for Safe Medication Practice’s QuarterWatch report found that Pradaxa patients who experienced internal bleeding were 5 times more likely to die in comparison to warfarin patients who suffered bleeding.*** On May 1st, the same journal published a study that showed head trauma victims were more likely to die from brain bleeding if they had been using Pradaxa compared to those taking the older blood thinner.****

Alleged victims of Pradaxa side effects may be entitled to compensation for their medical bills, lost wages, pain and suffering and more. Additional information regarding Pradaxa bleeding is available at Bernstein Liebhard LLP’s website. To arrange for a free Pradaxa lawsuit consultation, please call 800-511-5092 today.

*bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html
**thejns.org/doi/full/10.3171/2012.2.JNS112132
***ismp.org/quarterwatch/pdfs/2012Q2.pdf
****thejns.org/doi/pdf/10.3171/2013.3.JNS12503

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.consumerinjurylawyers.com

Read the full story at http://www.prweb.com/releases/pradaxa-lawsuit/pradaxa-lawsuit/prweb10770330.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Lawsuit on Pradaxa Brain Hemorrhage: Now, AttorneyOne Can Provide Advice
2. DrugRisks Update: New Study Warns of Pradaxa Brain Bleeding
3. Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation
4. Pradaxa Lawsuit Update: Bernstein Liebhard LLP Notes Filings in Federal Pradaxa Litigation Surpass 700
5. DrugRisks Update: Latest Court Figures Show Rise In Pradaxa Lawsuits
6. Rottenstein Law Group LLP Responds to Study Linking Pradaxa Side Effects with Potential Mortality Risks
7. Update on Pradaxa Internal Bleeding Problem Allegations Lawsuits; Resource4thePeople Reports Bellwether Trial Dates Scheduled
8. Pradaxa Lawyers at Bernstein Liebhard LLP Comment on New Study Highlighting the Risk of Pradaxa Brain Bleeding
9. DrugRisks Update: Warning Added to Pradaxa For Blood Condition
10. Pradaxa Lawsuits Move Forward, With Scheduling of Next Status Conference in Federal Pradaxa Litigation, Bernstein Liebhard LLP Reports
11. DrugRisk Update: Court Asks for Pradaxa Lawsuit Test Cases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: